Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001104659-22-023948 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-15 | RYTM | Chien Jennifer | EVP, Head of North America | S - Sale+OE | $6.10 | -722 | 1,310 | -36% | -$4,404 |
| D | 2022-02-15 | 2022-02-11 | RYTM | Chien Jennifer | EVP, Head of North America | M - OptEx | — | +2,032 | 2,032 | New | — |
| D | 2022-02-15 | 2022-02-11 | RYTM | Chien Jennifer | EVP, Head of North America | M - OptEx | $0.00 | -2,032 | 6,093 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | S | D | 722 | $6.10 | 1,310 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-11 | M | A | 2,032 | — | 2,032 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. |
| 3 | Derivative | Restricted Stock Units | 2022-02-11 | M | D | 2,032 | $0.00 | 6,093 | D | — · — to — | 2,032 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. (F3) The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date. |